PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.
作者信息
Seem Debbie L, Lee Ingi, Umscheid Craig A, Kuehnert Matthew J
机构信息
Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, Office of Blood, Organ, and other Tissue Safety, Atlanta, GA 30329, USA.
出版信息
Public Health Rep. 2013 Jul;128(4):247-343. doi: 10.1177/003335491312800403.
Abstract
摘要
相似文献
1
PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.通过器官移植减少人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒传播的公共卫生服务指南。
Public Health Rep. 2013 Jul;128(4):247-343. doi: 10.1177/003335491312800403.
2
Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.PHS 指南摘录：减少通过器官移植传播 HIV、HBV 和 HCV。
Am J Transplant. 2013 Aug;13(8):1953-62. doi: 10.1111/ajt.12386.
3
Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.评估实体器官捐献者和监测人类免疫缺陷病毒、乙型肝炎病毒和丙型肝炎病毒感染的移植受者-美国卫生与公众服务部 2020 年指南。
MMWR Recomm Rep. 2020 Jun 26;69(4):1-16. doi: 10.15585/mmwr.rr6904a1.
4
Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.已故器官捐献者和 PHS 风险识别：对器官使用和结果的影响。
Transplantation. 2017 Jul;101(7):1670-1678. doi: 10.1097/TP.0000000000001716.
5
Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.实体器官移植中传染病供体器官传播风险增加的利用：疾病传播与安全性的回顾性分析
Transpl Infect Dis. 2017 Dec;19(6). doi: 10.1111/tid.12791. Epub 2017 Nov 3.
6
Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.量化公共卫生服务中高危献血者中未检出的 HIV、乙肝病毒或丙肝病毒感染的风险。
Am J Transplant. 2019 Sep;19(9):2583-2593. doi: 10.1111/ajt.15393. Epub 2019 May 10.
7
The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.“PHS 增加风险”标签与每年数百个器官未被利用有关。
Transplantation. 2017 Jul;101(7):1666-1669. doi: 10.1097/TP.0000000000001673.
8
Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.从“增加感染风险供者”进行器官移植：Nord Italia 移植项目的经验——一项回顾性研究。
Transpl Int. 2018 Feb;31(2):212-219. doi: 10.1111/tri.13086. Epub 2017 Nov 7.
9
Impact of US Public Health Service increased risk deceased donor designation on organ utilization.美国公共卫生服务署提高死亡风险供体指定对器官利用的影响。
Am J Transplant. 2019 Sep;19(9):2560-2569. doi: 10.1111/ajt.15388. Epub 2019 May 3.
10
Public health safety and transplant with increased-risk organs: striking the balance.公共卫生安全与高风险器官移植：寻求平衡
Exp Clin Transplant. 2015 Apr;13 Suppl 1:9-12.
引用本文的文献
1
Exploring the attitudes of solid organ transplant recipients towards COVID-19 shielding communications and the language of 'clinically extremely vulnerable': a qualitative study investigating lessons for the future.探索实体器官移植受者对新冠病毒防护沟通及“临床极度脆弱”表述的态度：一项关于未来经验教训的定性研究
BMJ Public Health. 2024 Mar 19;2(1):e000695. doi: 10.1136/bmjph-2023-000695. eCollection 2024 Jun.
2
Real-world data to improve organ and tissue donation policies: lessons learned from the tissue and organ donor epidemiology study.真实世界数据改善器官和组织捐献政策：从组织和器官捐献者流行病学研究中汲取的经验教训。
Health Res Policy Syst. 2024 Nov 12;22(1):152. doi: 10.1186/s12961-024-01237-0.
3
Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States.美国取消普遍筛查后已故器官捐献者的人类嗜T淋巴细胞病毒筛查实践
Transplant Direct. 2024 Sep 17;10(10):e1707. doi: 10.1097/TXD.0000000000001707. eCollection 2024 Oct.
4
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?用丙型肝炎感染的肝脏扩大全球肝脏供体库，时机到了吗？
World J Transplant. 2024 Jun 18;14(2):90382. doi: 10.5500/wjt.v14.i2.90382.
5
6
Incomplete tissue product tracing during an investigation of a tissue-derived tuberculosis outbreak.在一次组织来源的结核病爆发调查中，组织产品的追溯不完整。
Am J Transplant. 2024 Jan;24(1):115-122. doi: 10.1016/j.ajt.2023.09.005. Epub 2023 Sep 15.
7
Prevention, diagnosis, and management of donor derived infections in pediatric kidney transplant recipients.小儿肾移植受者供体源性感染的预防、诊断及管理
Front Pediatr. 2023 Apr 21;11:1167069. doi: 10.3389/fped.2023.1167069. eCollection 2023.
8
Organ Transplantation Outcomes of Deceased Organ Donors in Organ Procurement Organization-Based Recovery Facilities Versus Acute-Care Hospitals.器官获取组织型复苏设施与急性医疗机构中已故器官捐献者的器官移植结局比较。
Prog Transplant. 2023 Jun;33(2):110-120. doi: 10.1177/15269248231164176. Epub 2023 Mar 21.
9
Evaluation of an Abnormal Liver Panel After Liver Transplantation.肝移植后异常肝酶谱的评估。
Clin Liver Dis. 2023 Feb;27(1):103-115. doi: 10.1016/j.cld.2022.08.006. Epub 2022 Oct 18.
10
Factors Underlying Racial Disparity in Utilization of Hepatitis C-Viremic Kidneys in the United States.美国丙型肝炎病毒血症肾脏利用中的种族差异的相关因素。
J Racial Ethn Health Disparities. 2023 Oct;10(5):2185-2194. doi: 10.1007/s40615-022-01398-0. Epub 2022 Aug 23.
本文引用的文献
1
Transmission of hepatitis C virus through transplanted organs and tissue--Kentucky and Massachusetts, 2011.通过移植器官和组织传播丙型肝炎病毒——肯塔基州和马萨诸塞州，2011 年。
MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1697-700.
2
Notes from the field: transplant-transmitted hepatitis B virus --- United States, 2010.现场记录：经器官移植传播的乙型肝炎病毒——美国，2010 年。
MMWR Morb Mortal Wkly Rep. 2011 Aug 19;60(32):1087.
3
Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.器官捐献者传染艾滋病毒和丙型肝炎病毒给四位器官接受者。
Am J Transplant. 2011 Jun;11(6):1218-25. doi: 10.1111/j.1600-6143.2011.03597.x.
4
Estimated risk of human immunodeficiency virus and hepatitis C virus infection among potential organ donors from 17 organ procurement organizations in the United States.美国 17 个器官获取组织中潜在器官捐献者感染人类免疫缺陷病毒和丙型肝炎病毒的风险估计。
Am J Transplant. 2011 Jun;11(6):1201-8. doi: 10.1111/j.1600-6143.2011.03518.x.
5
HIV transmitted from a living organ donor--New York City, 2009.HIV 经活体器官捐献者传播--纽约市，2009 年。
MMWR Morb Mortal Wkly Rep. 2011 Mar 18;60(10):297-301.
6
Potential transmission of viral hepatitis through use of stored blood vessels as conduits in organ transplantation--Pennsylvania, 2009.2009 年宾夕法尼亚州，使用储存血管作为器官移植移植物导致病毒性肝炎潜在传播。
MMWR Morb Mortal Wkly Rep. 2011 Feb 18;60(6):172-4.
7
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report.器官捐献者的核酸检测（NAT）：“最佳”检测是否就是正确的检测？共识会议报告。
Am J Transplant. 2010 Apr;10(4):889-899. doi: 10.1111/j.1600-6143.2009.02992.x. Epub 2010 Jan 29.
8
Updating the guideline development methodology of the Healthcare Infection Control Practices Advisory Committee (HICPAC).更新医疗保健感染控制实践咨询委员会（HICPAC）的指南制定方法。
Am J Infect Control. 2010 May;38(4):264-73. doi: 10.1016/j.ajic.2009.12.005. Epub 2010 Jan 29.
9
Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion.人类免疫缺陷病毒1型、丙型肝炎病毒和乙型肝炎病毒的传染性及输血传播风险。
Transfusion. 2009 Nov;49(11):2454-89. doi: 10.1111/j.1537-2995.2009.02322.x. Epub 2009 Jul 21.
10
The epidemiology and prevention of donor-derived infections.供体源性感染的流行病学与预防
Adv Chronic Kidney Dis. 2009 Jul;16(4):234-41. doi: 10.1053/j.ackd.2009.05.002.
Zotero 插件